Total Payments
$3,115
2024 Payments
$729.93
Companies
19
Transactions
84
Medicare Patients
2,219
Medicare Billing
$137,056
Payment Breakdown by Category
Food & Beverage$3,115 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,115 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $736.43 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $544.04 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $369.26 | 20 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $345.91 | 10 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $297.19 | 10 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $226.87 | 3 | $0 (2024) |
| Novo Nordisk Inc | $119.54 | 3 | $0 (2022) |
| Kiniksa Pharmaceuticals, Ltd. | $103.05 | 1 | $0 (2022) |
| Medtronic, Inc. | $80.39 | 1 | $0 (2022) |
| United Therapeutics Corporation | $71.74 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $729.93 | 8 | AstraZeneca Pharmaceuticals LP ($305.69) |
| 2023 | $977.87 | 31 | AstraZeneca Pharmaceuticals LP ($219.30) |
| 2022 | $831.12 | 28 | Novartis Pharmaceuticals Corporation ($187.50) |
| 2021 | $575.99 | 17 | Janssen Pharmaceuticals, Inc ($222.28) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $103.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $69.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $110.31 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $77.14 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $85.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $70.38 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $89.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $64.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/20/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Cardiology | ||||||
| 07/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $66.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: DIABETES | ||||||
| 06/15/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $66.49 | General |
| 05/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.84 | General |
| Category: Cardiology | ||||||
| 04/19/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: WATCHMAN_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 450 | 486 | $93,036 | $26,561 |
| 2022 | 5 | 634 | 738 | $140,178 | $42,049 |
| 2021 | 5 | 619 | 710 | $99,958 | $40,058 |
| 2020 | 5 | 516 | 583 | $58,778 | $28,387 |
Total Patients
2,219
Total Services
2,517
Medicare Billing
$137,056
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 324 | 339 | $67,122 | $17,763 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 91 | $18,018 | $6,271 | 34.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 28 | $4,032 | $1,450 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 28 | $3,864 | $1,078 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 475 | 555 | $109,890 | $31,930 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 80 | $15,840 | $5,663 | 35.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 37 | $5,328 | $1,727 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 37 | 38 | $5,244 | $1,668 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $3,300 | $978.73 | 29.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 16 | 16 | $576.00 | $81.92 | 14.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 415 | 470 | $69,193 | $27,954 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 97 | $15,282 | $7,135 | 46.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 42 | 56 | $8,064 | $2,638 | 32.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 22 | 22 | $4,672 | $1,698 | 36.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 16 | 16 | $983.20 | $372.52 | 37.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 45 | 49 | $1,764 | $261.32 | 14.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 334 | 375 | $37,176 | $19,395 | 52.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 64 | 89 | $12,816 | $4,308 | 33.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 62 | 62 | $5,680 | $3,225 | 56.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $1,844 | $831.82 | 45.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 22 | 22 | $686.40 | $549.12 | 80.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 15 | 16 | $576.00 | $78.91 | 13.7% |
About Jennifer Laporte, N.P
Jennifer Laporte, N.P is a Nurse Practitioner healthcare provider based in Midland, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2019. The National Provider Identifier (NPI) number assigned to this provider is 1568012797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Laporte, N.P has received a total of $3,115 in payments from pharmaceutical and medical device companies, with $729.93 received in 2024. These payments were reported across 84 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,115).
As a Medicare-enrolled provider, Laporte has provided services to 2,219 Medicare beneficiaries, totaling 2,517 services with total Medicare billing of $137,056. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Midland, MI
- Active Since 09/19/2019
- Last Updated 09/19/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1568012797
Products in Payments
- NUCALA (Biological) $400.41
- XARELTO (Drug) $297.19
- FARXIGA (Drug) $275.12
- ENTRESTO (Drug) $242.70
- DUPIXENT (Biological) $226.87
- BREZTRI (Drug) $195.22
- JARDIANCE (Drug) $147.76
- LEQVIO (Drug) $126.56
- TEZSPIRE (Biological) $125.00
- Arcalyst (Drug) $103.05
- Ozempic (Drug) $100.18
- MICRA (Device) $80.39
- AREXVY (Drug) $77.14
- BRILINTA (Drug) $70.71
- FASENRA (Biological) $70.38
- XIFAXAN (Drug) $39.92
- Assure WCD (Device) $38.73
- NEXLETOL (Drug) $38.40
- LifeVest (Device) $23.74
- Rybelsus (Drug) $19.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Midland
Kelli Overway, Aprn, Fnp-Bc, APRN, FNP-BC
Nurse Practitioner — Payments: $7,750
Nurse Practitioner $7,750
Steven Laporte
Nurse Practitioner — Payments: $6,837
Nurse Practitioner $6,837
Michael Hester, Agacnp-Bc, AGACNP-BC
Nurse Practitioner — Payments: $4,079
Nurse Practitioner $4,079
Jamie Trumble
Nurse Practitioner — Payments: $3,044
Nurse Practitioner $3,044
Megan Casselman, Np, NP
Nurse Practitioner — Payments: $3,031
Nurse Practitioner $3,031
Beth Spiris, Np, NP
Nurse Practitioner — Payments: $2,572
Nurse Practitioner $2,572